Curis
CRIS
#10201
Rank
C$24.11 M
Marketcap
C$1.87
Share price
0.00%
Change (1 day)
-66.33%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -C$45.86 Million

According to Curis's latest financial reports the company's current earnings are C$11.65 Million. In 2024 the company made an earning of -C$59.1 Million, an increase over its 2023 earnings that were of -C$62.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$45.86 Million-22.41%
2024 -C$59.1 Million-5.77%
2023 -C$62.72 Million-13.1%
2022 -C$72.17 Million27.52%
2021 -C$56.6 Million65.09%
2020 -C$34.28 Million-9.1%
2019 -C$37.71 Million-4.73%
2018 -C$39.58 Million-41.95%
2017 -C$68.18 Million-14.37%
2016 -C$79.63 Million3.55%
2015 -C$76.89 Million271.52%
2014 -C$20.7 Million76.64%
2013 -C$11.72 Million
2011 -C$9.96 Million27.76%
2010 -C$7.79 Million-43.87%
2009 -C$13.88 Million-23.44%
2008 -C$18.13 Million56.66%
2007 -C$11.57 Million-16.71%
2006 -C$13.9 Million-36.92%
2005 -C$22.03 Million156.25%
2004 -C$8.6 Million-37.24%
2003 -C$13.7 Million-93.34%
2002 -C$0.21 Billion86.79%
2001 -C$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Exelixis
EXEL
C$1.20 B-2,782.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.22 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-C$85.49 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.36 Billion 687.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.37 B-36,502.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$11.09 B-24,772.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-C$34.16 Million-24.06%๐Ÿ‡บ๐Ÿ‡ธ USA